bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s share price was down 12.5% during trading on Monday . The stock traded as low as $0.35 and last traded at $0.35. Approximately 2,556 shares were traded during trading, a decline of 75% from the average daily volume of 10,313 shares. The stock had previously closed at $0.40.
bioAffinity Technologies Stock Performance
The company’s 50 day simple moving average is $0.18 and its 200 day simple moving average is $0.16.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
See Also
- Five stocks we like better than bioAffinity Technologies
- Stock Market Sectors: What Are They and How Many Are There?
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 High-Yield Banks for Investors to Buy on the Dip
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
